JEMTEC Balance Sheet Health

Financial Health criteria checks 6/6

JEMTEC has a total shareholder equity of CA$2.3M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$2.5M and CA$193.7K respectively.

Key information

Debt to equity ratio

CA$0

Debt

Interest coverage ratio	n/a
Cash	CA$2.30m
Equity	CA$2.31m
Total liabilities	CA$193.68k
Total assets	CA$2.50m

Recent financial health updates

No updates

Recent updates

Is JEMTEC Inc.'s(CVE:JTC) Recent Stock Performance Tethered To Its Strong Fundamentals?

Mar 11

With EPS Growth And More, JEMTEC (CVE:JTC) Is Interesting

Feb 02

What Did JEMTEC's (CVE:JTC) CEO Take Home Last Year?

Jan 07

Are Robust Financials Driving The Recent Rally In JEMTEC Inc.'s (CVE:JTC) Stock?

Dec 10

Financial Position Analysis

Short Term Liabilities: JTC's short term assets (CA$2.5M) exceed its short term liabilities (CA$193.7K).

Long Term Liabilities: JTC has no long term liabilities.

Debt to Equity History and Analysis

Debt Level: JTC is debt free.

Reducing Debt: JTC has not had any debt for past 5 years.

Debt Coverage: JTC has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: JTC has no debt, therefore coverage of interest payments is not a concern.

JEMTEC Balance Sheet Health

Financial Health criteria checks 6/6

Key information

Recent financial health updates

Recent updates

Second quarter 2024 earnings released: EPS: CA$0.005 (vs CA$0.033 loss in 2Q 2023)

Insufficient new directors

Insufficient new directors

JEMTEC Inc. Announces Resignation of Gordon Baker as Director

Full year 2023 earnings released: CA$0.072 loss per share (vs CA$0.20 profit in FY 2022)

JEMTEC Inc., Annual General Meeting, Jan 31, 2024

Insufficient new directors

Insufficient new directors

Insufficient new directors

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: CA$0.027 loss per share (vs CA$0.042 profit in 3Q 2022)

Insufficient new directors

Insufficient new directors

Insufficient new directors

Estimating The Intrinsic Value Of JEMTEC Inc. (CVE:JTC)

Second quarter 2023 earnings released: CA$0.033 loss per share (vs CA$0.055 profit in 2Q 2022)

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 26%

Investor sentiment deteriorates as stock falls 22%

Full year 2022 earnings released: EPS: CA$0.20 (vs CA$0.20 in FY 2021)

JEMTEC Inc., Annual General Meeting, Jan 26, 2023

Insufficient new directors

Investor sentiment improved over the past week

Here's Why We Think JEMTEC (CVE:JTC) Might Deserve Your Attention Today

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CA$0.042 (vs CA$0.034 in 3Q 2021)

Investor sentiment improved over the past week

Insufficient new directors

Second quarter 2022 earnings released: EPS: CA$0.055 (vs CA$0.054 in 2Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Insufficient new directors

Third quarter 2021 earnings released: EPS CA$0.034 (vs CA$0.032 in 3Q 2020)

Does JEMTEC (CVE:JTC) Deserve A Spot On Your Watchlist?

Second quarter 2021 earnings released: EPS CA$0.054 (vs CA$0.035 in 2Q 2020)

Is JEMTEC Inc.'s(CVE:JTC) Recent Stock Performance Tethered To Its Strong Fundamentals?

With EPS Growth And More, JEMTEC (CVE:JTC) Is Interesting

What Did JEMTEC's (CVE:JTC) CEO Take Home Last Year?

First Dividend Is CA$0.25 Per Share

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CA$0.051

New 90-day high: CA$1.60

Investor sentiment improved over the past week

Are Robust Financials Driving The Recent Rally In JEMTEC Inc.'s (CVE:JTC) Stock?

New 90-day high: CA$1.42

Full year 2020 earnings released: EPS CA$0.15

New 90-day high: CA$1.38

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies